February 18, 2026 | HearFromHer, RareDisease
In the world of rare diseases, success is often measured by the speed of diagnosis. However, for women facing rare liver conditions like Intrahepatic Cholestasis of Pregnancy (ICP), the medical system often defaults to “normalizing” debilitating symptoms.

Listen to the full episode here.
In the latest episode of the Hear From Her podcast, Tatyana Kushner (Weill Cornell Medicine) and Andrea Goldstein (Mirum Pharmaceuticals), discuss why this status quo is dangerous. While ICP might present as “just an itch,” it is a complex condition where elevated bile acids can lead to severe risks for the infant, including respiratory distress or stillbirth.
The Data Behind the Disparities Recent research led by Dr. Kushner suggests a 70% recurrence rate for ICP in subsequent pregnancies. Furthermore, the data reveals significant racial disparities; for instance, while Primary Biliary Cholangitis (PBC) was long thought to be a condition primarily affecting Northern European women, it is now clear that women of color face significant barriers to diagnosis and access to care.
Listen to the full episode here.
The Future of Care: Genetics and Advocacy
As Andrea Goldstein puts it, “Every failure in a study leads to key learnings that help us be successful the next time.” For the modern clinician and patient alike, the goal is clear: don’t just learn the system—have the courage to change it. Listen to the full episode here.
Follow us for updates on upcoming podcasts and more insightful conversations.
For more information, please contact Jelena Spyropoulos.
About Medscape Education
Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free CME and CE courses for physicians, nurses, and other healthcare professional
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
At the European Society of Cardiology (ESC) Congress, two of cardiology’s most influential voices sat down to talk about artificial intelligence at Medscape’s ‘The Pulse of AI Innovation’ event: Professor…
Healthcare is changing rapidly, bringing unprecedented data and complex treatment pathways to the point of care. Clinical mastery requires active experience, the confidence to make decisions when real patient outcomes…
When independent, evidence-based education directly connects with clinicians at the point of care, clinical practice changes. Driven by this vital mission, Medscape Education was proud to sponsor The John Ritter…
We have officially wrapped up another year at ESC. For Medscape Education, 4 days on the ground confirmed what 3 decades of cardiovascular education have already shown: when independent, evidence-based…
In the high-stakes world of healthcare research and product development, success has long been measured by rigid definitions of precision and predictable trajectories. However, as Dr. Hawa Dumbuya, Director of…
For more than 30 years, Medscape Education has built independent, accredited cardiovascular education designed around one goal: improved patient outcomes. This year at the European Society of Cardiology Congress (ESC…
The phrase “patient-centered care” is tossed around freely in healthcare corporate boardrooms. Yet, for more than half the population, that promise routinely fractures. In the latest episode of the Hear…
Medscape Education has been honoured with the prestigious APEX Grand Award for Publication Excellence at…
For decades, the rate of spontaneous preterm birth in the United States has hovered stubbornly around 10%. Despite advancements in other areas of medicine, prematurity remains the second leading cause…
Medscape Education, the leading global provider of continuing medical education (CME), has announced its agenda for the upcoming 12th Congress of the European Academy of Neurology (EAN) 2026 in Geneva,…
